1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Klebsiella Pneumoniae Infection Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ATI-1503
1.4.3 CA-824
1.4.4 CC-1807
1.4.5 Cefiderocol
1.4.6 Debio-1454
1.4.7 EBX-004
1.4.8 Others
1.5 Market by Application
1.5.1 Global Klebsiella Pneumoniae Infection Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Klebsiella Pneumoniae Infection Drug Market
1.8.1 Global Klebsiella Pneumoniae Infection Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Klebsiella Pneumoniae Infection Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Klebsiella Pneumoniae Infection Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Klebsiella Pneumoniae Infection Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Klebsiella Pneumoniae Infection Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Klebsiella Pneumoniae Infection Drug Sales Volume
3.3.1 North America Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Klebsiella Pneumoniae Infection Drug Sales Volume
3.4.1 East Asia Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.5.1 Europe Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.6.1 South Asia Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.8.1 Middle East Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.9.1 Africa Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.10.1 Oceania Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.11.1 South America Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Klebsiella Pneumoniae Infection Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Klebsiella Pneumoniae Infection Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Klebsiella Pneumoniae Infection Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Klebsiella Pneumoniae Infection Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Klebsiella Pneumoniae Infection Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Klebsiella Pneumoniae Infection Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Klebsiella Pneumoniae Infection Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Klebsiella Pneumoniae Infection Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Klebsiella Pneumoniae Infection Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Klebsiella Pneumoniae Infection Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Klebsiella Pneumoniae Infection Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Klebsiella Pneumoniae Infection Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Klebsiella Pneumoniae Infection Drug Consumption Volume by Application (2015-2020)
15.2 Global Klebsiella Pneumoniae Infection Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Klebsiella Pneumoniae Infection Drug Business
16.1 Acies Bio doo
16.1.1 Acies Bio doo Company Profile
16.1.2 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Specification
16.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Innovation Pharmaceuticals Inc
16.2.1 Innovation Pharmaceuticals Inc Company Profile
16.2.2 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.2.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Evaxion Biotech ApS
16.3.1 Evaxion Biotech ApS Company Profile
16.3.2 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Specification
16.3.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Appili Therapeutics
16.4.1 Appili Therapeutics Company Profile
16.4.2 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Specification
16.4.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 ImmunoClin Corp
16.5.1 ImmunoClin Corp Company Profile
16.5.2 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Specification
16.5.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Debiopharm International SA
16.6.1 Debiopharm International SA Company Profile
16.6.2 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Specification
16.6.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Melinta Therapeutics Inc
16.7.1 Melinta Therapeutics Inc Company Profile
16.7.2 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.7.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 FOB Synthesis Inc
16.8.1 FOB Synthesis Inc Company Profile
16.8.2 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.8.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 F. Hoffmann-La Roche Ltd
16.9.1 F. Hoffmann-La Roche Ltd Company Profile
16.9.2 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Specification
16.9.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Kyorin Pharmaceutical Co Ltd
16.10.1 Kyorin Pharmaceutical Co Ltd Company Profile
16.10.2 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification
16.10.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Sarepta Therapeutics Inc
16.11.1 Sarepta Therapeutics Inc Company Profile
16.11.2 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.11.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Tetraphase Pharmaceuticals Inc
16.12.1 Tetraphase Pharmaceuticals Inc Company Profile
16.12.2 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.12.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Nosopharm SAS
16.13.1 Nosopharm SAS Company Profile
16.13.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Specification
16.13.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Shionogi & Co Ltd
16.14.1 Shionogi & Co Ltd Company Profile
16.14.2 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification
16.14.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Phico Therapeutics Ltd
16.15.1 Phico Therapeutics Ltd Company Profile
16.15.2 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Specification
16.15.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Peptilogics Inc
16.16.1 Peptilogics Inc Company Profile
16.16.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.16.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Syntiron LLC
16.17.1 Syntiron LLC Company Profile
16.17.2 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Specification
16.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Pfizer Inc
16.18.1 Pfizer Inc Company Profile
16.18.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Specification
16.18.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis
17.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
17.4 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Klebsiella Pneumoniae Infection Drug Distributors List
18.3 Klebsiella Pneumoniae Infection Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Klebsiella Pneumoniae Infection Drug (2021-2026)
20.2 Global Forecasted Revenue of Klebsiella Pneumoniae Infection Drug (2021-2026)
20.3 Global Forecasted Price of Klebsiella Pneumoniae Infection Drug (2015-2026)
20.4 Global Forecasted Production of Klebsiella Pneumoniae Infection Drug by Region (2021-2026)
20.4.1 North America Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.2 East Asia Market Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.3 Europe Market Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Countriy
21.4 South Asia Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.5 Southeast Asia Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.6 Middle East Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.7 Africa Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.8 Oceania Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.9 South America Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
21.10 Rest of the world Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer